Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

SYK kinases

Syk kinase inhibitors which have progressed to clinical studies 387... [Pg.379]

The crystal structure of the tandem Src-homology 2 (SH2) domain from Syk kinase in complex with a double phosphorylated ITAM peptide has been determined at a resolution of 3 A [13]. The two adjacent Syk C-terminal and N-terminal SH2 domains are required for localization to the membrane and are fundamentally important in the activation of Syk kinase. If the interaction of the... [Pg.381]

In the proper cellular context in B cells, NK cells and mast cells, Syk kinase has been shown to transduce cell growth and survival signals by activating PI3K/Akt and Ras/mitogen-activated protein kinase pathways [3,46]. When deregulated, Syk activity can promote myelodysplasias, leukemogenesis, and perhaps viral-media ted cellular transformations [47,48]. By contrast, Syk has also been proposed to function as a tumor suppressor [49]. This is however, based on... [Pg.385]

Compound 6 inhibited Syk kinase with K = 0.01 gM, and less potently inhibited Lyn, Fyn, Src, Itk, Btk, PKCot and PKC0 with KjS = 0.75, 2.05, 5.0, >9.5, >10, >15 and >15gM, respectively, and blocked antigen presentation of IC in mouse bone marrow-derived dentritic cells [59]. Inhibition of IL4 production (EC50 = 1.08 gM) was measured to ascertain inhibition of antigen presentation of IC by dendritic cells to T cells. [Pg.386]

A number of other small molecule Syk kinase inhibitors have been reported in the literature [61-64], Since there are no reports of detailed evaluation or animal efficacy data, some of these inhibitors may not have advanced further. [Pg.387]

Poque, S.L., Kurosaki, T., Bolen, J., Herbst, R., 2000, B ceU antigen receptor-induced activation of Akt promotes B ceU survival and is dependent on Syk kinase. J. Immunol. [Pg.331]

A series of novel 1,6-naphtyridine derivatives were prepared as potential inhibitors of human topoisomerase I (2003JMC2254), farnesyltransferase inhibitors (2003USP2003199544), p38 mitogen-activated protein kinase inhibitors (2003MI7), SYK kinase inhibitors (2003PIAW02003057695) and spleen tyrosine kinase inhibitors (2003MI8). [Pg.260]

Yagi, S. Suzuki, K. Hasegawa, A. Okumura, K. Ra, C. Cloning of the cDNA for the deleted syk kinase homologous to ZAP-70 from human basophilic leukemia cell line (KU812). Biochem. Biophys. Res. Commun., 200, 28-34 (1994)... [Pg.604]

The crystal structure of the tandem SH2 domain of the Syk kinase has also been solved in complex with a dpITAM peptide (Fiitterer et al., 1998). This structure is similar to that of Zap-70 (1) the peptide binding sites of each SH2 domain are spatially colinear so that a single dpITAM peptide bridges the two SH2 domains (2) an a-helical coiled coil links the two SH2 domains (3) the peptide and tandem SH2 domains bind... [Pg.187]


See other pages where SYK kinases is mentioned: [Pg.199]    [Pg.271]    [Pg.184]    [Pg.110]    [Pg.379]    [Pg.379]    [Pg.379]    [Pg.379]    [Pg.379]    [Pg.380]    [Pg.380]    [Pg.380]    [Pg.380]    [Pg.380]    [Pg.381]    [Pg.382]    [Pg.382]    [Pg.382]    [Pg.382]    [Pg.383]    [Pg.384]    [Pg.386]    [Pg.386]    [Pg.386]    [Pg.386]    [Pg.387]    [Pg.387]    [Pg.388]    [Pg.389]    [Pg.196]    [Pg.258]    [Pg.973]    [Pg.567]    [Pg.176]    [Pg.438]   
See also in sourсe #XX -- [ Pg.371 ]

See also in sourсe #XX -- [ Pg.438 ]




SEARCH



Syk Kinase as a Therapeutic Target for Disease

© 2024 chempedia.info